Josep M. Llovet, MD is ICREA Research Prof, Liver Cancer Translational Oncology Lab, Liver Unit, IDIBAPS, Hospital Clinic, Univ. Barcelona, Prof.of Medicine and Director of the Liver Cancer Program at Icahn Mount Sinai School of Medicine, NY. He has published 287 manuscripts in Liver Cancer, including NEJM, Lancet, Nature, Nat.Genet., Cancer Cell and Gastroenterology (IF:4052;citations:66339;h-index:105). Top 1% most cited researcher globally, Clarivate Analytics (2014-19), Educational Councilor (2013-15), President of ILCA (2011-13), Senior Editor of CCR, he has lectured in more than 604 international meetings and has been the PI of European grants FP7-HEPTROMIC,HEP-CAR, Accelerator Award, NIH-NIDDK R01-award, I+D and competitive private grants. His achievements are: 1.Establish a clinical and molecular classification for HCC. 2.Establish efficacy of chemoembolization and sorafenib for HCC.3.Identification of novel drivers and oncogenic pathways in HCC and ICC.